Viking Therapeutics (VKTX)

13.83 -0.61 (4.22%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/7/18 *Est.)

Latest Headlines

Form SC 13G Viking Therapeutics, Filed by: FMR LLC October 10, 2018 10:05 AM - SEC Filing Viking Therapeutics (VKTX) Highlights Positive Data from In Vivo Study of VK2809 October 8, 2018 7:03 AM - StreetInsider Viking Therapeutics Announces Data from In Vivo Study of VK2809 Presented at Oral Plenary Session of the 88th Annual Meeting of American Thyroid Association (ATA) October 8, 2018 7:02 AM - PR NewsWire Viking Therapeutics (VKTX) Announces VK2809 Phase 2 Study Results Selected for Oral Late-Breaker Presentation at AASLD October 4, 2018 7:02 AM - StreetInsider Viking Therapeutics Announces VK2809 Phase 2 Study Results Selected for Oral Late-Breaker Presentation at The Liver MeetingĀ® 2018 October 4, 2018 7:02 AM - PR NewsWire Viking Therapeutic (VKTX) PT Raised to $31 at H.C. Wainwright October 1, 2018 7:14 AM - StreetInsider Viking Therapeutics (VKTX) Highlights 'Positive New Findings' from Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture October 1, 2018 7:07 AM - StreetInsider Viking Therapeutics Presents Results from Phase 2 Study of VK5211 in Patients Recovering from Hip Fracture in Plenary Oral Presentation at ASBMR 2018 Annual Meeting October 1, 2018 7:02 AM - PR NewsWire Form 4 Viking Therapeutics, For: Jul 13 Filed by: LIGAND PHARMACEUTICALS INC September 27, 2018 9:27 PM - SEC Filing Viking Therapeutics to Participate in Upcoming Investor Conferences September 26, 2018 7:35 AM - PR NewsWire Form 424B5 Viking Therapeutics, September 21, 2018 4:19 PM - SEC Filing Form 8-K Viking Therapeutics, For: Sep 20 September 21, 2018 6:07 AM - SEC Filing Viking Therapeutics (VKTX) Prices 9.5M Share Offering at $18.50/Sh September 21, 2018 5:40 AM - StreetInsider Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock September 20, 2018 8:06 PM - PR NewsWire Form 424B5 Viking Therapeutics, September 19, 2018 4:28 PM - SEC Filing Viking Therapeutics (VKTX) Announces Proposed Common Share Offering September 19, 2018 4:23 PM - StreetInsider Viking Therapeutics Announces Proposed Public Offering of Common Stock September 19, 2018 4:21 PM - PR NewsWire Viking Therapeutic (VKTX) PT Raised to $28 at Maxim Group September 19, 2018 7:49 AM - StreetInsider Viking Therapeutic (VKTX) PT Raised to $28 at SunTrust Robinson Humphrey September 18, 2018 3:39 PM - StreetInsider Viking Therapeutic (VKTX) PT Raised to $28 at Maxim Group, Matching 'Street High' September 18, 2018 12:31 PM - StreetInsider Viking Therapeutic (VKTX) PT Raised to 'Street High' $28 at H.C. Wainwright September 18, 2018 11:57 AM - StreetInsider Pre-Open Movers 09/18: (VKTX) (NXEO) (TLRY) Higher; (MDGL) (ATHN) (CBRL) Lower (more...) September 18, 2018 9:24 AM - StreetInsider Viking Therapeutics (VKTX): VK2809 Phase II Data Tops Madrigal's MGL-3196 - SunTrust September 18, 2018 8:33 AM - StreetInsider Viking Therapeutics (VKTX) Climbs 140% After Shares Resume Trading September 18, 2018 7:37 AM - StreetInsider Viking Therapeutics (VKTX) to Resume Trading at 7:35 am ET September 18, 2018 7:17 AM - StreetInsider Form 8-K Viking Therapeutics, For: Sep 18 September 18, 2018 7:11 AM - SEC Filing Viking Therapeutics (VKTX) Says Phase 2 Study of VK2809 in Patients with NAFLD and Elevated LDL-Cholesterol Achieved its Primary Endpoint September 18, 2018 7:08 AM - StreetInsider Viking Therapeutics Announces Positive Top-Line Results from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol September 18, 2018 7:05 AM - PR NewsWire Viking Therapeutics (VKTX) Halted, News Pending September 18, 2018 7:00 AM - StreetInsider Viking Therapeutics to Participate in Upcoming Investor Conferences August 28, 2018 7:30 AM - PR NewsWire Form 10-Q Viking Therapeutics, For: Jun 30 August 9, 2018 5:14 PM - SEC Filing Form 8-K Viking Therapeutics, For: Aug 09 August 9, 2018 4:30 PM - SEC Filing Viking Therapeutics (VKTX) Misses Q2 EPS by 2c August 9, 2018 4:08 PM - StreetInsider Viking Therapeutics Reports Second Quarter 2018 Financial Results and Provides Corporate Update August 9, 2018 4:05 PM - PR NewsWire Viking Therapeutics to Report Financial Results for Second Quarter 2018 on August 9, 2018 August 2, 2018 7:30 AM - PR NewsWire Full Article List